Seminars in Perinatology
Volume 33, Issue 3 , Pages 196-205 , June 2009

Imitators of Severe Pre-eclampsia

  • Baha M. Sibai, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Baha M. Sibai, MD, Department of Obstetrics and Gynecology, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267

References 

  1. Sibai BM. Imitators of severe preeclampsia. Obstet Gynecol. 2007;109:956–966
  2. Usta IM, Barton JR, Amon EA, et al. Acute fatty liver of pregnancy: An experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol. 1994;171:1342–1347
  3. Castro MA, Fassett MJ, Reynolds TB, et al. Reversible peripartum liver failure: A new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy based on 28 consecutive cases. Am J Obstet Gynecol. 1999;181:389–395
  4. Reyes H. Acute fatty liver of pregnancy. Clin Liver Dis. 1999;3:69–81
  5. Pereira S, O'Donohue J, Wendon J, Williams R. Maternal and perinatal outcome in severe pregnancy related liver disease. J Hepatol. 1997;26:1258–1262
  6. Vigil-DeGracia P, Lavergue JA. Acute fatty liver of pregnancy. Int J Gynecol Obstet. 2001;72:193–195
  7. Davidson KM, Simpson LL, Knox TA, et al. Acute fatty liver in triplet gestation. Obstet Gynecol. 1998;91:806–808
  8. Moldenhauer JS, O'Brien JM, Barton JR, et al. Acute fatty liver of pregnancy associated with pancreatitis: A life-threatening complication. Am J Obstet Gynecol. 2004;190:502–506
  9. Fesenmeier MF, Coppage KH, Lambers DS, et al. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol. 2005;192:1416–1419
  10. Castro MA, Goodwin TM, Shaw KJ, et al. Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy. Am J Obstet Gynecol. 1996;174:211–216
  11. Knight M, Nelson-Piercy C, Kurinczuk JJ UK obstetric surveillance system (UKOSS). A prospective national study of acute fatty liver of pregnancy in the UK. Gut. 2008;57:951–956
  12. Suzuki S, Watanalie S, Araki T. Acute fatty liver of pregnancy at 23 weeks of gestation. Br J Obstet Gynaecol. 2001;108:223–224
  13. de Nagy J, Strittmatter CA, Lee RV. Acute fatty liver of pregnancy presenting as hepatic encephalopathy at 28 weeks' gestation. J Obstet Gynaecol. 2008;28:100–102
  14. Martin JN, Briery CM, Rose CH, et al. Postpartum plasma exchanges adjunctive therapy for severe acute fatty liver of pregnancy. J Clin Apher. 2008;23:138–143
  15. Sibai BM. Diagnosis, controversies, and management of HELLP syndrome. Obstet Gynecol. 2004;103:981–991
  16. Mabie W, Dacus J, Sibai BM, et al. Computed tomography in acute fatty liver of pregnancy. Am J Obstet Gynecol. 1988;158:142–145
  17. Van Le L, Podrasky A. Computed tomographic and ultrasonographic findings in women with acute fatty liver of pregnancy. J Reprod Med. 1990;35:815–817
  18. Farine D, Newhouse J, Owen J, et al. Magnetic resonance imaging and computed tomography scan for the diagnosis of acute fatty liver of pregnancy. Am J Perinatol. 1990;7:316–318
  19. Clements D, Young W, Thornton J, et al. Imaging in acute fatty liver of pregnancy. Br J Obstet Gynaecol. 1990;97:631–633
  20. Castro M, Ouzounian JG, Colletti PM, et al. Radiologic studies in acute fatty liver of pregnancy (A review of the literature and 19 new cases). J Reprod Med. 1996;41:839–843
  21. Knox TA, Olans LB. Liver disease in pregnancy (Review article). N Engl J Med. 1996;335:569–576
  22. Zang Z, Yamada J, Zhao Y, et al. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. JAMA. 2002;288:2163–2166
  23. Rajasri AG, Sretha R, Mitchell J. Acute fatty liver of pregnancy (AFLP): An overview. J Obstet Gynaecol. 2007;27:237–240
  24. Tyni T, Ekholm E, Pihko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol. 1998;178:603–608
  25. Ibdah JA, Bennett MJ, Rinaldo P, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med. 1999;340:1723–1731
  26. Martin JN, Bailey AP, Rehberg JF, et al. Thrombotic thrombocytopenic purpura in 166 pregnancies, 1955-2006. Am J Obstet Gynecol. 2008;199:98–104
  27. Hayward CPM, Sutton DMC, Carter WH, et al. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Arch Intern Med. 1994;154:982–987
  28. Ezra Y, Rose M, Elder A. Therapy and prevention of thrombotic thrombocytopenic purpura during pregnancy: A clinical study of 16 pregnancies. Am J Hematol. 1996;51:1–6
  29. Egerman SS, Witlin AG, Friedman SA, et al. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in pregnancy: Review of 11 cases. Am J Obstet Gynecol. 1996;175:950–956
  30. Dashe JS, Ramin SM, Cunningham FG. The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy. Obstet Gynecol. 1998;91:662–668
  31. Castella M, Rujol M, Julia A, et al. Thrombotic thrombocytopenic purpura and pregnancy: A review of ten cases. Vox Sang. 2004;87:287–290
  32. Vesely SK, Li X, McMinn JR, et al. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2004;44:1149–1158
  33. Shamseddine A, Chehal A, Usta I, et al. Thrombotic thrombocytopenic purpura and pregnancy report of four cases and literature review. J Clin Apher. 2004;19:5–10
  34. Dulcoy-Bouthars AS, Caron C, Sulitil D, et al. Thrombotic thrombocytopenic purpura: Medical and biological monitoring of six pregnancies. Eur J Obstet Gynecol Reprod Biol. 2003;111:146–152
  35. Stella CA, Dacus J, Guzman E, et al: The diagnostic dilemma of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the obstetric triage and emergency department. Lessons from 4 tertiary hospitals. Am J Obstet Gynecol Epub: doi:10.1016/j.acog.2008.10.037
  36. Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347:589–600
  37. Allford SL, Hunt BJ, Rose P, et al. Guideline-guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anemias. Br J Haematol. 2003;120:556–573
  38. George JN. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006;354:1927–1935
  39. George JN, Terrell DR, Swisher KK, et al. Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry. J Clin Apher. 2008;23:129–137
  40. Thorp JM, White GD, Moake JL, et al. Willebrand factor multimeric levels and patterns in patients with severe preeclampsia. Obstet Gynecol. 1990;75:163–167
  41. Lattuada A, Rossi E, Calzarossa C, et al. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTs-13) in pregnant women with HELLP microangiopathic syndrome. Haematologica. 2003;88:1029–1034
  42. Hulstim JJJ, van Rumard Heimel PJ, Fraux A, et al. Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome. J Thromb Haemost. 2006;4:2569–2575
  43. Bartz C, Brandenburg V, Rath W. Is von-Willebrand-cleaving protease (ADAMTs-13) useful in differentiating HELLP from TTP. Hypertens Pregnancy. 2004;23(Suppl 1):abstract no. 69
  44. Hebisch G, Bernasconi MT, Ganuer J, et al. Pregnancy-associated recurrent hemolytic uremic syndrome with fetal thrombotic vasculopathy in the placenta. Am J Obstet Gynecol. 2001;185:1265–1266
  45. Pajor A, Hintalan A, Bakos L, et al. Postpartum hemolytic uremic syndrome following placental abruption. Eur J Obstet Gynecol Reprod Biol. 1993;49:201–204
  46. Martinez-Roman S, Gratacos E, Torne A, et al. Successful pregnancy in a patient with hemolytic-uremic syndrome during the second trimester of pregnancy. J Reprod Med. 1996;41:211–214
  47. Rosen M, Brauer KI, Alperin JB, et al. Postpartum hemorrhagic shock resulting in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. J Matern Fetal Neonatal Med. 2003;13:208–210
  48. Weiner CP. Thrombotic microangiopathy in pregnancy and the postpartum period. Semin Hematol. 1987;24:119–129
  49. Jamshed S, Kouides P, Sham R, et al. Pathology of thrombotic thrombocytopenic purpura in the placenta, with emphasis on the “snowman sign.”. Pediatr Dev Pathol. 2007;10:455–462
  50. Strasser SM, Kwee A, Fijnheer R, et al. Transient severe fetal heart rate abnormalities in pregnancy complicated by thrombotic thrombocytopenic purpura. Obstet Gynecol. 2008;111:517–521
  51. Cortes-Hernandez J, Ordi-Ros J, Paredes F, et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: A prospective study of 103 pregnancies. Rheumatology. 2002;41:643–650
  52. Clark CA, Spitzer KA, Nadler JN, et al. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol. 2003;30:2127–2132
  53. Tandon A, Ibanez D, Gladman DD, et al. The effect of pregnancy on lupus nephritis. Arthritis Rheum. 2004;50:3941–3946
  54. Clowse MEB, Magder L, Petri M. Cyclophosphamide for lupus during pregnancy. Lupus. 2005;14:593–597
  55. Chakravarty EF, Colon I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol. 2005;192:1897–1904
  56. Egerman RS, Ramsey RD, Kao LW, et al. Hypertensive disease in pregnancies complicate by systemic lupus erythematosus. Am J Obstet Gynecol. 2005;193:1676–1679
  57. Dahr JP, Essenmacher LM, Ager JW, et al. Pregnancy outcome before and after diagnosis of systemic lupus erythematosus. Am J Obstet Gynecol. 2005;193:1444–1455
  58. Hilbrand P, Eignmann C, Gugger M, et al. Pre-eclampsia with acute heart failure postpartum as primary manifestation of systemic lupus erythematosus. Eur J Heart Fail. 2005;7:1057–1058
  59. Ticani A, Bompane D, Danieli E, et al. Pregnancy, lupus and antiphospholipid syndrome (Hughes Syndrome). Lupus. 2006;15:15761160
  60. Hanly JG. Antiphospholipid syndrome: An overview. CMAJ. 2003;168:1675–1682
  61. Levine JS, Branch DW, Rauch D. The antiphospholipid syndrome. N Engl J Med. 2002;346:752–763
  62. Kupferminc MJ, Lee MJ, Green D, et al. Severe postpartum pulmonary, cardiac, and renal syndrome associated with antiphospholipid antibodies. Obstet Gynecol. 1994;83:806–807
  63. Kniaz D, Eisenberg GM, Ebrad H, et al. Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies: A case report and review of the literature. Am J Nephrol. 1992;12:126–133
  64. Amant F, Spitz B, Arnout J, et al. Hepatic necrosis and hemorrhage in pregnant patients with antiphospholipid antibodies. Lupus. 1997;6:552–555
  65. Fehr T, Cathomas G, Weber C, et al. Foetal loss, liver necrosis and acute lupus erythematosus in a patient with antiphospholipid antibody syndrome. Lupus. 2001;10:576–579
  66. Roberts G, Gordon MM, Porter D, et al. Acute renal failure complicating HELLP syndrome, SLE, and antiphospholipid syndrome: Successful outcome using plasma exchange therapy. Lupus. 2003;12:251–257
  67. Sakhel K, Usta IM, Hannoun A, et al. Liver infarction in a woman with lupus nephritis and antiphospholipid syndrome. Scand J Rheumatol. 2006;35:405–408
  68. Lockshin MD, Erkan D. Treatment of antiphospholipid syndrome. N Engl J Med. 2003;349:1177–1179
  69. Klein NA, Mabie WC, Shaver DC, et al. Herpes simplex virus hepatitis in pregnancy (Two patients successfully treated with acyclovir). Gastroenterology. 1991;100:239–244
  70. Kang AH, Graves CR. Herpes simplex hepatitis in pregnancy: A case report and review of the literature. Obstet Gynecol. 1999;54:463–468
  71. Maupin RT. Obstetric infectious disease emergencies. Clin Obstet Gynecol. 2002;45:393–404
  72. Allen RH, Tuomala RE. Herpes simplex virus hepatitis causing acute liver dysfunction and thrombocytopenia in pregnancy. Obstet Gynecol. 2005;106:1187–1189
  73. Mabie WC, Barton JR, Sibai BM. Septic shock in pregnancy. Obstet Gynecol. 1997;90:553–561
  74. Afessa B, Green B, Delke I, et al. Systemic inflammatory response syndrome, organ failure, and outcome in critically ill obstetric patients treated in an ICU. Chest. 2001;120:1271–1277
  75. KanKuri E, Kurki T, Carlson P, et al. Incidence, treatment and outcome of peripartum sepsis. Acta Obstet Gynecol Scand. 2003;82:730–735
  76. Fernandez-Perez ER, Salam S, Pendem S, et al. Sepsis during pregnancy. Crit Care Med. 2005;33:S286–S293
  77. Sheffield JS. Sepsis and septic shock in pregnancy. Crit Care Clin. 2004;20:651–660
  78. Russell JA. Management of sepsis. N Engl J Med. 2006;355:1699–1713
  79. Von Dadelszen P, Magee LA, Marshall JC, et al. The maternal syndrome of preeclampsia: A forme fruste of the systemic inflammatory response syndrome. Sepsis. 2000;4:43–47
  80. VonDadelszen P, Magee LA, Lee SK, et al. Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: A therapeutic opportunity?. Crit Care Med. 2002;30:1883–1892

PII: S0146-0005(09)00008-1

doi: 10.1053/j.semperi.2009.02.004

Seminars in Perinatology
Volume 33, Issue 3 , Pages 196-205 , June 2009

Article Tools

* Image Usage & Resolution